相关实验视频

Updated: Jun 24, 2025

Modeling Charcot-Marie-Tooth Disease In Vitro by Transfecting Mouse Primary Motoneurons

Modeling Charcot-Marie-Tooth Disease In Vitro by Transfecting Mouse Primary Motoneurons

Published on: January 7, 2019

对CMT神经病变的基因疗法:从临床到诊所

Marina Stavrou¹, Kleopas A Kleopa^1,2

¹Neuroscience Department, The Cyprus Institute of Neurology and Genetics.

Current opinion in neurology

|June 14, 2024

概括

基因疗法对Charcot-Marie-Tooth (CMT) 神经病变有希望,在动物模型中取得了早期成功. 需要进一步的研究来解决临床应用之前的交付,安全和监管障碍.

科学领域:

神经学神经学
遗传学遗传学是一个
生物技术是生物技术.

背景情况:

查洛-玛丽-牙 (CMT) 包含罕见的,渐进的和遗传多样性的神经病变.
目前的CMT治疗主要是支持性和症状性,缺乏经批准的修改疾病的治疗方法.

研究的目的:

对各种类型的CMT进行基因治疗策略的最新进展进行审查.
突出将这些疗法从临床前研究转化为临床实践的潜力和挑战.

主要方法:

对CMT的基因治疗方法的当前文献的综述.
从动物和较大的动物模型中分析临床前数据.
讨论临床翻译方面的挑战,包括输送,剂量和安全性.

主要成果:

有希望的病毒性和非病毒性基因疗法候选人已经出现,这是由于对CMT病理机制的理解增加.
几种基因疗法已经在相关动物模型中证明了概念的证明.
关键的挑战包括优化输送路径,确定适当的剂量以及评估潜在的非目标效应和毒性.

结论:

基因疗法是治疗CMT神经病变的有希望的途径.
成功的临床翻译需要解决安全,监管和后勤方面的考虑.
制定共识指南和优化临床试验设计对于推进CMT基因疗法的发展至关重要.

更多相关视频

In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration

In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration

Published on: June 15, 2018

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies

Published on: July 29, 2007

相关概念视频

Gene Therapy

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...